116 related articles for article (PubMed ID: 32741713)
1. Mitochondrial expression of the DNA repair enzyme OGG1 improves the prognosis of pancreatic ductal adenocarcinoma.
Inokuchi S; Itoh S; Yoshizumi T; Yugawa K; Yoshiya S; Toshima T; Takeishi K; Iguchi T; Sanefuji K; Harada N; Sugimachi K; Ikegami T; Kohashi K; Taguchi K; Yonemasu H; Fukuzawa K; Oda Y; Mori M
Pancreatology; 2020 Sep; 20(6):1175-1182. PubMed ID: 32741713
[TBL] [Abstract][Full Text] [Related]
2. Prognostic impact of 8-hydroxy-deoxyguanosine and its repair enzyme 8-hydroxy-deoxyguanosine DNA glycosylase in hepatocellular carcinoma.
Yugawa K; Itoh S; Yoshizumi T; Yoshiya S; Takeishi K; Toshima T; Harada N; Ikegami T; Kohashi K; Oda Y; Mori M
Pathol Int; 2020 Aug; 70(8):533-541. PubMed ID: 32419286
[TBL] [Abstract][Full Text] [Related]
3. Mitochondrial 8-oxoguanine glycosylase decreases mitochondrial fragmentation and improves mitochondrial function in H9C2 cells under oxidative stress conditions.
Torres-Gonzalez M; Gawlowski T; Kocalis H; Scott BT; Dillmann WH
Am J Physiol Cell Physiol; 2014 Feb; 306(3):C221-9. PubMed ID: 24304833
[TBL] [Abstract][Full Text] [Related]
4. Oxidative DNA damage in human esophageal cancer: clinicopathological analysis of 8-hydroxydeoxyguanosine and its repair enzyme.
Kubo N; Morita M; Nakashima Y; Kitao H; Egashira A; Saeki H; Oki E; Kakeji Y; Oda Y; Maehara Y
Dis Esophagus; 2014 Apr; 27(3):285-93. PubMed ID: 23902537
[TBL] [Abstract][Full Text] [Related]
5. The Role of DNA Repair Glycosylase OGG1 in Intrahepatic Cholangiocarcinoma.
Sakata K; Yoshizumi T; Izumi T; Shimokawa M; Itoh S; Ikegami T; Harada N; Toshima T; Mano Y; Mori M
Anticancer Res; 2019 Jun; 39(6):3241-3248. PubMed ID: 31177174
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the prognostic impact of pre- and post-operative CA19-9, SPan-1, and DUPAN-II levels in patients with pancreatic carcinoma.
Kondo N; Murakami Y; Uemura K; Nakagawa N; Takahashi S; Ohge H; Sueda T
Pancreatology; 2017; 17(1):95-102. PubMed ID: 27746094
[TBL] [Abstract][Full Text] [Related]
7. Preoperative CEA and CA 19-9 are prognostic markers for survival after curative resection for ductal adenocarcinoma of the pancreas - a retrospective tumor marker prognostic study.
Distler M; Pilarsky E; Kersting S; Grützmann R
Int J Surg; 2013; 11(10):1067-72. PubMed ID: 24161419
[TBL] [Abstract][Full Text] [Related]
8. Oxidative DNA damage and its repair in rat spleen following subchronic exposure to aniline.
Ma H; Wang J; Abdel-Rahman SZ; Boor PJ; Khan MF
Toxicol Appl Pharmacol; 2008 Dec; 233(2):247-53. PubMed ID: 18793663
[TBL] [Abstract][Full Text] [Related]
9. Comparing prognostic factors of Glut-1 expression and maximum standardized uptake value by FDG-PET in patients with resectable pancreatic cancer.
Takahashi M; Nojima H; Kuboki S; Horikoshi T; Yokota T; Yoshitomi H; Furukawa K; Takayashiki T; Takano S; Ohtsuka M
Pancreatology; 2020 Sep; 20(6):1205-1212. PubMed ID: 32819845
[TBL] [Abstract][Full Text] [Related]
10. High levels of serum glypican-1 indicate poor prognosis in pancreatic ductal adenocarcinoma.
Zhou CY; Dong YP; Sun X; Sui X; Zhu H; Zhao YQ; Zhang YY; Mason C; Zhu Q; Han SX
Cancer Med; 2018 Nov; 7(11):5525-5533. PubMed ID: 30358133
[TBL] [Abstract][Full Text] [Related]
11. Increased susceptibility of chronic ulcerative colitis-induced carcinoma development in DNA repair enzyme Ogg1 deficient mice.
Liao J; Seril DN; Lu GG; Zhang M; Toyokuni S; Yang AL; Yang GY
Mol Carcinog; 2008 Aug; 47(8):638-46. PubMed ID: 18300266
[TBL] [Abstract][Full Text] [Related]
12. Post-adjuvant chemotherapy CA19-9 levels predict prognosis in patients with pancreatic ductal adenocarcinoma: A retrospective cohort study.
Imaoka H; Shimizu Y; Senda Y; Natsume S; Mizuno N; Hara K; Hijioka S; Hieda N; Tajika M; Tanaka T; Ishihara M; Niwa Y; Yamao K
Pancreatology; 2016; 16(4):658-64. PubMed ID: 27178104
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial transcription factor a worsens the clinical course of patients with pancreatic cancer through inhibition of apoptosis of cancer cells.
Yamauchi M; Nakayama Y; Minagawa N; Torigoe T; Shibao K; Yamaguchi K
Pancreas; 2014 Apr; 43(3):405-10. PubMed ID: 24622070
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of preoperative prognostic factors in patients with resectable pancreatic ductal adenocarcinoma.
Izumo W; Higuchi R; Furukawa T; Yazawa T; Uemura S; Shiihara M; Yamamoto M
Scand J Gastroenterol; 2019 Jun; 54(6):780-786. PubMed ID: 31180790
[No Abstract] [Full Text] [Related]
15. Preoperative maximum standardized uptake value and carbohydrate antigen 19-9 were independent predictors of pathological stages and overall survival in Chinese patients with pancreatic duct adenocarcinoma.
Gu X; Zhou R; Li C; Liu R; Zhao Z; Gao Y; Xu Y
BMC Cancer; 2019 May; 19(1):456. PubMed ID: 31092213
[TBL] [Abstract][Full Text] [Related]
16. Immunolocalization of 8-OHdG and OGG1 in pancreatic islets of streptozotocin-induced diabetic rats.
Ku YP; Jin M; Kim KH; Ahn YJ; Yoon SP; You HJ; Chang IY
Acta Histochem; 2009; 111(2):138-44. PubMed ID: 18676009
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of B2M and loss of ALK7 expression are associated with invasion, metastasis, and poor-prognosis of the pancreatic ductal adenocarcinoma.
Liu C; Yang Z; Li D; Liu Z; Miao X; Yang L; Zou Q; Yuan Y
Cancer Biomark; 2015; 15(6):735-43. PubMed ID: 26406402
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of γ-glutamyltransferase-to-albumin ratio in patients with pancreatic ductal adenocarcinoma following radical surgery.
Li S; Xu H; Wu C; Wang W; Jin W; Gao H; Li H; Zhang S; Xu J; Zhang W; Xu S; Li T; Ni Q; Yu X; Liu L
Cancer Med; 2019 Feb; 8(2):572-584. PubMed ID: 30632317
[TBL] [Abstract][Full Text] [Related]
19. Tenascin C in the Tumor-Nerve Microenvironment Enhances Perineural Invasion and Correlates With Locoregional Recurrence in Pancreatic Ductal Adenocarcinoma.
Furuhashi S; Sakaguchi T; Murakami T; Fukushima M; Morita Y; Ikegami K; Kikuchi H; Setou M; Takeuchi H
Pancreas; 2020 Mar; 49(3):442-454. PubMed ID: 32132519
[TBL] [Abstract][Full Text] [Related]
20. A novel combined carbohydrate antigen 19-9 and lymphocyte-to-monocyte ratio score can predict early recurrence of resectable pancreatic ductal adenocarcinoma.
Yugawa K; Maeda T; Nagata S; Sakai A; Taketani K; Yamaguchi S; Konishi K; Hashimoto K
Surg Today; 2023 Oct; 53(10):1199-1208. PubMed ID: 36943449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
